Navigation Links
Queen's researchers pioneer needle-free test for premature babies
Date:4/13/2011

Scientists at Queen's University Belfast have pioneered a new needle-free test to take the sting out of medicine testing in premature babies. The research will not only lead to greater accuracy in prescribing, but will also significantly reduce the trauma of such tests for newborn infants and their families.

In the first published research project worldwide on this new approach to testing medicines in children, the findings were announced in leading US medical journal Pediatrics.

The study, which involves the use of blood spots obtained from a simple heel-prick, took place in the Belfast Hospital for Sick Children and the School of Pharmacy at Queen's.

The research was carried out by a team from the University's School of Pharmacy in partnership with the Regional Neonatal Unit in the Royal Maternity Hospital. It was funded by the Health and Social Care Research and Development Office (HSC R&D) and Action Medical Research.

Principal Investigator, Queen's Professor of Pharmacy Practice James McElnay said: "This type of testing will obviously reduce the discomfort of medicine testing in these vulnerable patients. What is even more important, however, is that it will ensure maximum accuracy in calculating the most appropriate dose of a medicine for a sick child.

"Some 80 per cent of infants in intensive care in hospitals receive medicines which have not been appropriately tested or licensed for use in such young patients, and the dosage is usually calculated based on licensed doses for adults or older children. Sizable blood samples are then required to measure the concentrations of the drug in the infant's bloodstream.

"Our work opens up opportunities for using the same approach to study other medicines which are used in this manner in children, and we are currently studying a number of these."

The Queen's study involved the antibiotic metronidazole. The research team used single drops of blood collected on blotting paper from premature infants who were receiving the medicine as part of their routine care. The 'spots' were dried, analysed in the University's School of Pharmacy, and the results used to develop dosage guidance for doctors.


'/>"/>

Contact: Anne Langford
a.langford@qub.ac.uk
028-909-75310
Queen's University Belfast
Source:Eurekalert

Related medicine news :

1. New York Personal Injury Lawyers Concerned About Toyota Accident in Queens
2. ENT and Allergy Associates Welcomes Tamekia L. Wakefield, MD, Further Reinforcing its Pediatric Sinus Expertise and Capabilities in Queens
3. Researchers map all the fragile sites of the yeast Saccharomyces cerevisiaes genome
4. UH Case Medical Center researchers publish promising findings for advanced cervical cancer
5. Researchers discover new way to kill pediatric brain tumors
6. Researchers Who Discovered First Genes for Stuttering will Present Findings to the National Stuttering Association
7. Researchers create drug to keep tumor growth switched off
8. Urine protein test might help diagnose kidney damage from lupus, UT Southwestern researchers find
9. GUMC researchers say flower power may reduce resistance to breast cancer drug tamoxifen
10. Clemson researchers develop hands-free texting application
11. Researchers find biomarkers in saliva for detection of early-stage pancreatic cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the ... Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , “We ... new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:6/25/2016)... ... , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department ... in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at ... Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 ...
(Date:6/24/2016)... ... , ... Those who have experienced traumatic events may suffer from a complex ... as drug or alcohol abuse, as a coping mechanism. To avoid this pain and ... a traumatic event. , Trauma sufferers tend to feel a range of emotions, from ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension ... that it will receive two significant new grants to support its work to ... its 25th anniversary by recognizing patients, medical professionals and scientists for their work ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is ... Road To Recovery® program to drive cancer patients to and from their cancer treatments. ... the highest quality of life and ongoing independence. Getting to and from medical ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Market - Forecast to 2022" report to their offering. ... method for the patients with kidney failure, it replaces the ... from the patient,s blood and thus the treatment helps to ... chloride in balance. Increasing number of ESRD ...
Breaking Medicine Technology: